Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Almirall, Athenex, Cerovene, Cyclo, Janssen, Lilly, Mallinckrodt, Meiragtx, Morphosys, Pfizer, Prevail, Sanofi, Takeda, Virpax.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acino, Astrazeneca, Atnahs, Azurrx, Bayer, Dynavax, Evqlv, Faron, GW, Hypera, Immunoprecise, Mateon, Ophirex, Sanofi, Sumitomo Dainippon, Takeda, Unum.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Albireo, Cytodyn, Evelo, Eyepoint, Galera, GW Pharmaceuticals, Karyopharm, Medivir, Merck, Orthotrophix, Urovant, VBI, Vivus.

Biopharmas raising money in public or private financings, including: AB Science, DBV, Enlivex, Evonetix, Marker, NLS, Oric, Passage Bio, Polyprox, Primmune, Theravance, Tonix, Vaxart, Verastem, Xilio.

Quarterly snapshots from biopharma companies with marketed products, including: Amicus.

New hires and promotions in the biopharma industry, including: Acacia, BC Platforms, Generex, Ovid.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amgen, Biohaven, Boehringer Ingelheim, Debiopharm, Lilly, Fennec, Innocoll, Mereo, Shionogi, Takeda.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agex, Altimmune, Generex, Graybug, Merck, Sonoma, Therapix.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antibe, Biodelivery, Galera, Huya, Ironwood Sorrento.

Biopharmas raising money in public or private financings, including: Aptorum, Cocrystal, Lipocine, Novan.